| 帕唑帕尼的临床应用和药品不良反应的研究进展 |
| |
| 引用本文： | 周陈建,赵嫏嬛,胡国新.帕唑帕尼的临床应用和药品不良反应的研究进展[J].药学实践杂志,2016,34(6):497-500. |
| |
| 作者姓名： | 周陈建 赵嫏嬛 胡国新 |
| |
| 作者单位： | 温州市中心医院, 浙江 温州 325000,温州市人民医院, 浙江 温州 325000,温州市医科大学, 浙江 温州 325000 |
| |
| 摘 要： | 帕唑帕尼是一种多靶点酪氨酸激酶抑制剂，研究发现帕唑帕尼主要用于治疗肾细胞癌、卵巢癌、乳腺癌和肺癌等疾病，并可能导致腹泻、高血压、头发褪色、恶心和厌食等不良反应。
|
| 关 键 词： | 帕唑帕尼 临床应用 不良反应 |
| 收稿时间： | 2015/12/22 0:00:00 |
| 修稿时间： | 2016/5/16 0:00:00 |
Progress of pazopanib in clinical applications and adverse drug reaction |
| |
| ZHOU Chenjian,ZHAO Langhuan and HU Guoxin.Progress of pazopanib in clinical applications and adverse drug reaction[J].The Journal of Pharmaceutical Practice,2016,34(6):497-500. |
| |
| Authors: | ZHOU Chenjian ZHAO Langhuan and HU Guoxin |
| |
| Institution: | Wenzhou Central Hospital, Wenzhou 325000, China,People''s Hospital of Wenzhou, Wenzhou 325000, China and Wenzhou Medical University, Wenzhou 325000, China |
| |
| Abstract: | Pazopanib is a multi-targeted tyrosine kinase inhibitor, and is mainly used to treat renal cell carcinoma, ovarian cancer, breast cancer, and lung cancer. The researchers also found that pazopanib may cause diarrhea, hypertension, hair loss, nausea, and anorexia. This paper reviewed pazopanib clinical application and adverse reactions, and provided a basis for this medication. |
| |
| Keywords: | pazopanib clinical application adverse reaction |
|
| 点击此处可从《药学实践杂志》浏览原始摘要信息 |
| 点击此处可从《药学实践杂志》下载免费的PDF全文 |
|
